Joe Ciaffoni is Chief Executive Officer of Indivior Pharmaceuticals, Inc. (INDV). The company reported total compensation of $18,501,214 for fiscal year 2025.
| Salary | $680,114 |
|---|---|
| Bonus | $0 |
| Stock awards | $15,319,404 |
| Option awards | $0 |
| Non-equity incentive plan | $2,100,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $401,696 |
| Total | $18,501,214 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Indivior Pharmaceuticals, Inc. filed March 27, 2026, accession 0001104659-26-035480.
| Peer-group chief executive median | $13,350,777 |
|---|---|
| Difference from that median | $5,150,437 |
| Percentile within the disclosed peer group | 84th |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Indivior Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joe Ciaffoni this page | Chief Executive Officer | $18,501,214 |
| Pat Barry | Chief Commercial Officer | $4,905,744 |
| Christian Heidbreder | Chief Scientific Officer | $4,182,548 |
| Richard Simkin | Former Chief Commercial Officer | $4,017,316 |
| Ryan Preblick | Chief Financial Officer | $3,592,393 |
| Jeff Burris | Chief Legal Officer | $3,521,215 |
| Mark Crossley | Former Chief Executive Officer | $3,185,591 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Indivior Pharmaceuticals, Inc. compensation brief.
Joe Ciaffoni's compensation sits inside Indivior Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Indivior Pharmaceuticals, Inc. (INDV) compensation brief